First Quarter Financial Results for Fiscal Year Ending March 2027 IFRS (Consolidated) [Supplement: Financial Results Summary Document]

Overview of results

For the first quarter of this term, consolidated net sales reached 234,330 million yen (up 15.6% YoY), driven by the growth of core products such as Leqvio, Daybigu, and Leqambi, along with the impact of a weaker yen, resulting in a substantial revenue increase. Operating income was 24,728 million yen (+19.2%), with core operating income at 24.7 billion yen (+13.9% YoY) expanding. Quarterly net income was 19,151 million yen, with net income attributable to owners of parent at 18,242 million yen. By segment, performance was solid across Japan, the Americas, China, EMEA, East Asia & Global South.

Outlook and financial position

Full-year consolidated net sales guidance is unchanged from the prior forecast. Total assets 1,558,091 million yen, total liabilities 624,922 million yen, share attributable to owners of parent 906,564 million yen. Cash and cash equivalents stood at 311,739 million yen, increasing. Cash flows from financing activities rose significantly, maintaining a healthy financial position with an increase in cash balance. As risk factors, exchange rate fluctuations and market conditions in various countries are noted, with additional information provided in the financial results supplementary materials and at the earnings briefing.